XGXue Gao

Xue Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xue Gao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Dan Ma

    Third Hospital of Shanxi Medical University

    1 shared publication
  • Jiale Wang

    Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China

    1 shared publication
  • Jian Zhao

    School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China

    1 shared publication
  • Jiannan Han

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    1 shared publication
  • Jie Kang

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    1 shared publication
  • Junhui Hao

    Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China

    1 shared publication

Latest Publications

  • Open Access

    The Role of Inflammatory Cytokines in the Causal Pathway From Gut Microbiota to Sjögren’s Syndrome: Evidence From Mendelian Randomization

    by Junkang Zhao, Jiannan Han, Xiuying Fan, Jie Kang, Ruonan Wu, Yixuan Zhao, Lina Bai, Xue Gao, Dan Ma, Liyun Zhang

    Purpose: Evidence is accumulating that links gut microbiota, a crucial component of the immune environment, to Sjogren’s syndrome (SS). The mechanisms underlying the influence of gut microbiota on the onset and development of SS are still not completely understood. To this end, we applied a Mendelian randomization (MR) framework to investigate whether inflammatory cytokines mediate the association of gut microbiota with SS. Methods: Our MR analysis leveraged publicly available GWAS data, including information on 211 gut microbiota taxa sourced from the MiBioGen consortium (18,340 participants), summary statistics for 91 inflammatory cytokines obtained from a study of 14,824 individuals, and genetic data for SS derived from the UK Biobank (407,746 participants). To investigate causal associations between gut microbiota and SS, we primarily employed the inverse variance weighted method, supported by additional techniques such as MR‐Egger, simple mode, weighted median, and weighted mode for validation. The potential mediating effect of inflammatory cytokines in the gut microbiota–SS relationship was investigated using both mediation MR and multivariable MR (MVMR) analyses. Results: MR analysis identified five microbiota taxa causally associated with SS. Particularly, class Gammaproteobacteria (OR = 3.468, 95% CI = 1.139–10.557, p = 0.029) and genus Peptococcus (OR = 1.722, 95% CI = 1.082–2.471, p = 0.022) were significantly associated with an increased risk of developing SS. Six inflammatory cytokines were identified as potentially causal, with Axin‐1 (OR = 2.556, 95% CI = 1.072–6.096, p = 0.034) and C‐X‐C motif chemokine 10 levels (CXCL10) (OR = 3.049, 95% CI = 1.428–6.513, p = 0.004) being the most critical contributors. Mediation MR analysis showed that Axin‐1 levels mediated 16.96% of the causal effect of class Gammaproteobacteria on SS, CXCL10 levels mediated 36.78% of the causal effect of genus Coprococcus3 on SS. Conclusion: The findings suggest that certain gut microbiota is sociated with an increased risk of SS, mediated by specific inflammatory cytokines.


  • Open Access

    Genetic evidence for the causal relations between metabolic syndrome and psychiatric disorders: a Mendelian randomization study

    by Xue Gao, Yi Qin, Shu Jiao, Junhui Hao, Jian Zhao, Jiale Wang, Yanchao Wen, Tong Wang

    Emerging evidence reveals associations between metabolic syndrome (MetS) and psychiatric disorders (PDs), although causality remains uncertain. Consequently, we conducted Mendelian randomization (MR) to systematically evaluate the causality between MetS and PDs. Linkage disequilibrium score regression estimated the heritability of PDs and their genetic correlations with MetS. In primary analyses, the main model employed inverse variance weighting method, with sensitivity analyses using various MR models to ensure robustness. Replication MR analyses, involving cohorts distinct from those in the primary analyses, were performed to validate the generalizability of the findings. Multivariable MR analyses were carried out to account for genetically predicted body mass index (BMI). As a result, genetic correlations of MetS with attention-deficit/hyperactivity disorder(ADHD), anorexia nervosa(ANO), major depressive disorder(MDD), and schizophrenia were identified. Causal effects of MetS on ADHD (OR: 1.59 [95% CI:1.45–1.74]), ANO (OR: 1.42 [95% CI:1.25–1.61]), MDD(OR: 1.23 [95% CI: 1.13–1.33]), and the effects of ADHD (OR: 1.03 [95% CI: 1.02–1.04]) and ANO (OR: 1.01 [95% CI: 1.01–1.02]) on MetS were observed in primary analyses. Results from sensitivity analyses and replication analyses were generally consistent with the primary analyses, confirming the robustness and generalizability of the findings. Associations between MetS and ADHD, as well as ANO persisted after adjusting for BMI, whereas the statistical significance of the association between MetS and MDD was no longer observable. These results contribute to a deeper understanding of the mechanisms underlying PDs, suggesting potential modifiable targets for public prevention and clinical intervention in specific PDs related to metabolic pathways.